Performance & Formulation Insights for AccessCARE Bright
How AccessCARE Bright Works
AccessCARE Bright is a clinically tested, phyto-derived brightening active combining Broussonetia papyrifera (Paper Mulberry) Bark Extract, Limonia acidissima (Wood Apple) Extract, and Nephelium longana (Longan) Seed Extract. This botanical blend delivers a multi-pathway approach to skin brightening through tyrosinase inhibition — targeting the enzyme responsible for melanin overproduction. Key bioactives including arbutin, Kazinol F, gallic acid, and ellagic acid work synergistically to promote a more even, luminous complexion while reducing the appearance of dark spots and hyperpigmentation.
Formulation Guidelines
AccessCARE Bright is a water-soluble liquid (in Butylene Glycol) designed for easy incorporation into the water phase of serums, essences, brightening creams, and spot treatments. The recommended use level is 3%. Add during the cool-down stage at temperatures below 40°C (104°F) to preserve the activity of the tyrosinase-inhibiting compounds. It is compatible within a cosmetic pH range of 4.5–6.5 and pairs well with other brightening actives such as niacinamide, vitamin C derivatives, alpha arbutin, and tranexamic acid for enhanced efficacy. Avoid combining with strong oxidizing agents that may degrade the polyphenol actives.
Key Formulation Benefits
- Clinically Tested Brightening: Demonstrated skin brightening efficacy in a 28-day clinical study at 3% use level.
- Multi-Pathway Tyrosinase Inhibition: Arbutin, Kazinol F, gallic acid, and ellagic acid target melanin production through complementary mechanisms.
- Dark Spot Reduction: Helps visibly reduce the appearance of hyperpigmentation and uneven skin tone.
- Naturally Derived & Vegan: 100% plant-sourced actives suitable for clean beauty and vegan formulations.
- Versatile & Easy to Use: Water-soluble liquid integrates seamlessly into brightening skincare formats at a 3% use level.
